Rx Only Takeda PRINCIPAL DISPLAY PANEL - Kit Carton - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4627-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521225 PRINCIPAL DISPLAY PANEL - Blister Label - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4627-02 Single-dose only 6521495 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
USA 122 , e2523019122 (2025)
(PubMed) Tanaka S, Haruma K, Yoshihara M, et al
in vitro with chemically reactive metabolites derived from several drugs displaying idiosyncratic toxicity, including troglitazone, acetaminophen, clozapine, and diclofenac (Okada et al., 2011
Boosts the immunity: Our IV service delivers essential nutrients that strengthen your immune system, helping your body fight off infections and illnesses more effectively
Whether melanotan II can cause skin cancer is one of the most concerning (and controversial) takes